Puretech Health
PureTech Health is a biotech company listed on the London Stock Exchange and included in the FTSE 250 Index.
It was founded in 2005 by Daphne Zohar. PureTech Health develops medicines to treat serious diseases. It has subsidiary companies focused on various therapeutic areas, including neuropsychiatric disorders, weight management, cognitive disorders, autoimmune diseases, and inflammatory diseases. They also have their own pipeline of therapeutics in immunology, lymphatics, and oncology.
| Company type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 2005 |
| Headquarters | Boston, United States |
Key people | Christopher Viehbacher (Chairman) Daphne Zohar (CEO) |
| Products | Medicines |
| Revenue |  $15.6 million (2022) |
| $(197.8) million (2022) | |
 $(37.4) million (2022) | |
| Website | puretechhealth |
References
This article uses material from the Wikipedia Simple English article PureTech Health, which is released under the Creative Commons Attribution-ShareAlike 3.0 license ("CC BY-SA 3.0"); additional terms may apply (view authors). Content is available under CC BY-SA 4.0 unless otherwise noted. Images, videos and audio are available under their respective licenses.
®Wikipedia is a registered trademark of the Wiki Foundation, Inc. Wiki Simple English (DUHOCTRUNGQUOC.VN) is an independent company and has no affiliation with Wiki Foundation.